Evidence map›Paper›PMID 28880842›Full record

ReviewBlood transfusion = Trasfusione del sangue2017

Current misconceptions in diagnosis and management of iron deficiency.

Manuel Muñoz, Susana Gómez-Ramírez, Martin Besser, José Pavía, Fernando Gomollón, Giancarlo M Liumbruno, Sunil Bhandari, Mercé Cladellas, Aryeh Shander, Michael Auerbach

Registry-linked trialAbstract readReview
In one paragraph

Review in Blood transfusion = Trasfusione del sangue, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04083755 (Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With Lower Extremity Peripheral Artery Disease), which is not on this map. Cited by 71 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04083755 phase4unknown statusnot on this mapstarted 2019, after this paper: background citation

Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With Lower Extremity Peripheral Artery Disease

TypeinterventionalSponsorBiobizkaia Health Research InstituteRan2019 to 2025Enrolled240ConditionsAnemia, Peripheral Arterial Occlusive DiseaseArmsFerric Carboxymaltose Injection [Injectafer], no treatment or oral iron supplementation
3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Iron Deficiency-More Than Just Anemia: A Literature Review.Journal of community hospital internal medicine perspectives · 2025
    Review
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Manuel MuñozPerioperative Transfusion Medicine, Department of Surgical Sciences, Biochemistry and Immunology, School of Medicine, University of Málaga, Málaga, Spain.
Susana Gómez-RamírezDepartment of Internal Medicine, University Hospital "Virgen de la Victoria", Málaga, Spain.
Martin BesserDepartment of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
José PavíaDepartment of Pharmacology, School of Medicine, University of Málaga, Málaga, Spain.
Fernando GomollónDepartment of Gastroenterology, University Hospital "Lozano Blesa", IIS Aragón, CIBERehd, Zaragoza, Spain.
Giancarlo M LiumbrunoItalian National Blood Centre, National Institute of Health, Rome, Italy.
Sunil BhandariMetabolic Research Unit, Hull and East Yorkshire Hospitals NHS Trust; Hull York Medical School, Kingston upon Hull, United Kingdom.
Mercé CladellasBiomedical Research Institute, University Hospital Mar-Esperança, Barcelona, Spain.
Aryeh ShanderDepartment of Anesthesiology, Critical Care Medicine, Pain Management and Hyperbaric Medicine, TeamHealth Research Institute, Englewood Hospital and Medical Centre, Englewood, NJ, United States of America.
Michael AuerbachGeorgetown University School of Medicine, Washington, DC, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevention and treatment of iron deficiency is a major public health goal. Challenges in the treatment of iron deficiency include finding and addressing the underlying cause and the selection of an iron replacement product which meets the needs of the patient. However, there are a number of non-evidence-based misconceptions regarding the diagnosis and management of iron deficiency, with or without anaemia, as well as inconsistency of terminology and lack of clear guidance on clinical pathways. In particular, the pathogenesis of iron deficiency is still frequently not addressed and iron not replaced, with indiscriminate red cell transfusion used as a default therapy. In our experience, this imprudent practice continues to be endorsed by non-evidence-based misconceptions. The intent of the authors is to provide a consensus that effectively challenges these misconceptions, and to highlight evidence-based alternatives for appropriate management (referred to as key points). We believe that this approach to the management of iron deficiency may be beneficial for both patients and healthcare systems. We stress that this paper solely presents the Authors' independent opinions. No pharmaceutical company funded or influenced the conception, development or writing of the manuscript.

Indexed as

Diagnostic ErrorsEvidence-Based PracticeIron DeficienciesAnemia, Iron-DeficiencyHumansIronIron

Identifiers

PMID28880842
PMCPMC5589705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.